NCT04569682View on ClinicalTrials.gov

Outcomes of Transrenal Artery Perfusion Versus Transrenal Vein Perfusion Using LifePort for Deceased Donor Kidney Transplantation

NACompletedINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

October 30, 2021

Study Completion Date

December 30, 2022

Conditions

Kidney TransplantationOrgan Preservation

Interventions

DEVICE

LifePort transrenal artery perfusion

transrenal artery perfusion group

DEVICE

LifePort transrenal vein perfusion

transrenal vein perfusion group

Trial Locations (1)

Unknown

West China Hospital, Sichuan University, Chengdu

All Listed Sponsors

lead

West China Hospital

OTHER

NCT04569682 - Outcomes of Transrenal Artery Perfusion Versus Transrenal Vein Perfusion Using LifePort for Deceased Donor Kidney Transplantation | Biotech Hunter | Biotech Hunter